Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03714880 · ClinicalTrials.gov registry record · Phase 2
Cervical Preparation With Mifepristone Prior to Osmotic Dilators
A Phase 2 study, sponsored by University of California, Davis.
- Terminated
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT03714880 is a Phase 2 study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 44 participants.
The verdict
NCT03714880, a Phase 2 study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
The investigators plan to study the role of mifepristone prior to the placement of cervical osmotic dilators to evaluate if the medication helps increase the number of dilators. This may help improve safety of dilation and evacuation (D\&E) procedures.
Interventions
- DRUG Placebo Oral Tablet
- DRUG Mifepristone 200 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-04-26 |
| Est. Completion | 2021-02-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03714880
The ClinicalTrials.gov registry entry for NCT03714880 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT03714880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03714880 about?
NCT03714880 is a clinical study titled "Cervical Preparation With Mifepristone Prior to Osmotic Dilators". The investigators plan to study the role of mifepristone prior to the placement of cervical osmotic dilators to evaluate if the medication helps increase the number of dilators. This may help improve safety of dilation and evacuation (D\&E) procedures.
What is the current status of trial NCT03714880?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2019-04-26. Estimated completion is 2021-02-26.
What interventions are being tested in trial NCT03714880?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Mifepristone 200 MG (DRUG).
Who is sponsoring clinical trial NCT03714880?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.